Cymat Technologies Ltd. CYMHF
$0.10
$0.0221.72%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 284.74% | -44.32% | -25.46% | -90.37% | -5.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 284.74% | -44.32% | -25.46% | -90.37% | -5.51% |
| Cost of Revenue | 70.77% | -27.29% | -72.44% | -70.71% | 328.87% |
| Gross Profit | 133.81% | -86.82% | 177.38% | -141.59% | -280.13% |
| SG&A Expenses | -5.60% | 9.37% | 35.15% | -15.48% | 3.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.89% | -11.62% | -9.25% | -54.22% | 41.56% |
| Operating Income | 34.24% | -106.52% | 2.48% | -224.02% | -58.42% |
| Income Before Tax | -33.67% | -80.95% | -3.16% | -118.88% | -49.46% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.67% | -80.95% | -3.16% | -118.88% | -49.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.67% | -80.95% | -3.16% | -118.88% | -49.46% |
| EBIT | 34.24% | -106.52% | 2.48% | -224.02% | -58.42% |
| EBITDA | 35.66% | -158.93% | 3.63% | -454.42% | -66.07% |
| EPS Basic | 17.02% | -20.90% | 20.75% | -86.67% | -56.67% |
| Normalized Basic EPS | 20.65% | -19.05% | 21.21% | -81.58% | -64.29% |
| EPS Diluted | 17.02% | -20.90% | 20.75% | -86.67% | -56.67% |
| Normalized Diluted EPS | 20.65% | -19.05% | 21.21% | -81.58% | -64.29% |
| Average Basic Shares Outstanding | 61.03% | 49.99% | 30.89% | 18.03% | -4.48% |
| Average Diluted Shares Outstanding | 61.03% | 49.99% | 30.89% | 18.03% | -4.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |